Zoetis (ZTS) EBIAT (2012 - 2026)

Zoetis (ZTS) has 15 years of EBIAT data on file, last reported at $601.0 million in Q1 2026.

• EBIAT for Q1 2026 came in at $601.0 million, changed 0.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.6 billion (up 5.76% YoY), and the FY2025 annual result was $2.7 billion, up 7.09% from the prior year.
• EBIAT was little changed at $601.0 million in Q1 2026 per ZTS's latest filing, from $603.0 million in the prior quarter.
• Over five years, EBIAT peaked at $721.0 million in Q3 2025 and troughed at $458.0 million in Q4 2022.
• A 5-year average of $599.7 million and a median of $599.0 million in 2024 frame the typical range for EBIAT.
• On a YoY basis, EBIAT climbed as much as 26.65% in 2023 and fell as far as 7.07% in 2023.
• A 5-year view of EBIAT shows it stood at $458.0 million in 2022, then gained by 15.07% to $527.0 million in 2023, then rose by 10.25% to $581.0 million in 2024, then gained by 3.79% to $603.0 million in 2025, then dropped by 0.33% to $601.0 million in 2026.
• Business Quant data shows ZTS's EBIAT at $601.0 million in Q1 2026, $603.0 million in Q4 2025, and $721.0 million in Q3 2025.